Trade Summary

6 days ago, Adar1 Capital Management, LLC, serving as 10% owner at Inmed Pharmaceuticals Inc. (INM), purchased 468,551 shares at $1.54 per share, for a total transaction value of $721,548.00. Following this transaction, Adar1 Capital Management, LLC now holds 800,000 shares of INM.

This purchase represents a 141.00% increase in Adar1 Capital Management, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 19, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 21, 2026 at 5:08 PM ET, 2 days after the trade was made.

Inmed Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.